Virios Therapeutics, Inc. VIRI
Set alert
0.16 +0.16 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 206.50K
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.97
- Beta
- 1.58
- Short ratio
- 0.64
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 4.51
- 200-d avg
- 7.69
- 1y target
- 3.00
Analyst view
Consensus: buy
Buy
Price target (mean) 3.00 +1835.5% upside
Now 0.155
- Target (low)
- 1.00
- Target (mean)
- 3.00
- Target (high)
- 5.00
Recommendation trend
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.06 – -0.05 | -0.06 | +16.7% | 0 | 0.0% | 2 |
| Next quarter | -0.05 | -0.06 – -0.05 | -0.06 | +16.7% | 0 | 0.0% | 2 |
| Current year | -0.22 | -0.23 – -0.21 | -0.28 | +21.4% | 0 | 0.0% | 2 |
| Next year | -0.16 | -0.17 – -0.16 | -0.22 | +27.3% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 19, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Dec 14, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
